Literature DB >> 4373024

Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.

M Velasco, K O'Malley, N W Robie, J Wells, Z H Israili, J L McNay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4373024     DOI: 10.1002/cpt19741661031

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

1.  Effect of clonidine on sympathetic nervous activity in hydralazine-treated hypertensive patients.

Authors:  M Velasco; H Bertoncini; E Romero; A Urbina-Quintana; J Guevara; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

Review 2.  Minoxidil: a review of its pharmacological properties and therapeutic use.

Authors:  V M Campese
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

3.  Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.

Authors:  M Velasco; J Guevara; J Morillo; A Ramírez; A Urbina-Quintana; O Hernández-Pieretti
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

4.  Possible significance of the pharmacological differentiation of beta-blockers for therapy of hypertension.

Authors:  F H Leenen
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.

Authors:  K O'Malley; M Velasco; J Wells; J McNay
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

6.  Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients.

Authors:  M Velasco; E Romero; H Bertoncini; A Urbina-Quintana; J Guevara; O Hernández-Pieretti
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

7.  Effect of minoxidil on sympathetic nervous activity in clonidine-treated hypertensive patients.

Authors:  M Velasco; A Urbina-Quintana; E Hernández; A Ramírez; R Aliendres; J Morillo; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.